20 Steps
Maximum: 9.5 CME cr., 9.5 MOC pts.
0 new discussion posts (2 published)
Sign in to view your progression
Program Overview
Learning Objectives
Target Audience
Credit Designation
Disclosures

Program Overview

This enduring activity is based on recordings of the live activity, Transplant Hepatology Review Course, provided September 17-18, 2016.

Release Date: September 23, 2016

Expiration Date: December 31, 2017

COMPONENTS
Online:
-Narrated modules each 20-25 minutes in length 
-Pre-and post-test questions for each module
-Evaluation

Registration

Review the registration type information below, before clicking on the "Register" link below.

  • Member: $300
  • Trainee and Associate Member: $175
  • Nonmember: $515
  • Nonmember Trainee/Associate: $225
  • Industry: $750

REGISTER

Cancellation Policy

Requests for cancellation must be submitted in writing to education@aasld.org.

Cancellations received on or before September 23, 2016 will be refunded in full. No refunds will be issued once course has been accessed.

System Requirements:
iPad/iPhone: iOS iPad or iPhone devices with iOS 7.0 with the latest LiverLearning® iOS App installed.
Click here to download it : LiverLearning® iOS App
Android devices: Requires Android 4.1 and up with the latest LiverLearning® App installed.
Click here to download it : LiverLearning® Android App
Desktop/Laptop Requirements:
Medium or Combination of Media Used:
- A recent web browser (cookies and javascript enabled) compatible with HTML5 applications
- Flash Player 9+ is required in order to view the modules and complete the accredited course. If you cannot start a module please click here to download and install the current version of the Flash Player.
- Operating system: MacOS/Windows

Internet Connection:
Broadband is recommended but not a must, users in locations with slow internet connection or with a 3G connection may participate in this program.
While it is in the best interest of participants to take the exam through a broadband connection or an LTE (4G) cellular connection rather than through a much slower connection, it is not an absolute requirement.

Screen Resolution:
iOS Apps: this complete program will adapt itself to fit with iPhone or iPad screens
Desktop/Laptop Screens: 800 x 600 or better, 1024 x 768 is preferred

Copyright:
All faculty in this activity have given their permission for publication OR ©2016 AASLD

Contact Information:
For questions on CME/MOC content or the activity web site, contact education@aasld.org.

- Discuss the diagnosis, natural history, and therapies for liver diseases leading to liver transplantation

- Discuss the management of patients awaiting liver transplantation

- Discuss the immediate post-operative and long term management of liver transplant recipients

- Discuss current organ allocation policy and its effects on selecting potential liver transplant recipients

Hepatologists

Fellows / Trainees

Continuing Medical Education (CME)

The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this enduring online activity for a maximum of 9.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this enduring medical education activity must complete the pre-test(s), view the presentation(s), successfully pass the post-test(s) for each module with a score of 70% or better, and complete an evaluation.

MOC Points

Physicians seeking ABIM MOC points must complete the CME evaluation in addition to completing the pre-test(s), viewing the presentation(s) and successfully passing the post-test(s) for each module for which they wish to receive points with a score of 70% or better. MOC points will be reported to the ABIM between the 15th and the 20th of each month, for participants who successfully complete the MOC pre- and post-tests.

Your MOC points will NOT be reported to ABIM until you have indicated to us that you are completely done with all of the lectures for which you wish to receive points. When you are certain that you have completed all of the lectures you wish to complete, please proceed to the “Final Evaluation & Certificate/Completion Confirmation” step. 

Complete the Final Evaluation form and download your certificate/Completion Confirmation. Once the certificate has been downloaded the points you have earned will be submitted to ABIM. YOU WILL NOT BE ABLE to earn any additional CME Credits or MOC points for any other lectures related to the Transplant Hepatology Review Course Enduring Activity (You may still review any of the lectures for information purposes only).  

Needs Statement

In 2016, the first group of ABIM certified transplant hepatologists will be due for recertification along with those who will have recently completed a fellowship in transplant hepatology. A comprehensive, focused course is needed to review the material that will be covered on the exam as represented by the ABIM blueprint.

 

Core Competencies

This activity was planned in the context of the following ACGME/IOM/IPEC competencies: Patient care and Procedural Skills, Medical knowledge, Systems-based practice, Practice-based learning and improvement, Patient-centered care, Work in interdisciplinary teams, Evidence-based practice, Quality improvement, Values/Ethics for interprofessional practice, Roles/Responsibilities, Interprofessional communication, and Teams and teamwork. 


Norah Terrault, MD, MPH    "Advisory Committees or Review Panels: Biotest, Eisai
Consulting: Achillion, BMS, Cocrystal, Janssen, Merck
Grant/Research Support: AbbVie, Biotest, Eisai, Gilead, Merck, Novartis, Vertex                                                        

Anna S. Lok, MD, FAASLD    "Advisory Committees or Review Panels: Gilead, MYR, Tekmira
Consulting: GSK, Merck
Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead, Idenix"

Naga P. Chalasani, MD, FAASLD    "Consulting: Abbvie, Celgene, Lilly, Merck/Anthem, NuSirt, Salix, Takeda, Tobira
Grant/Research Support: Galectin, Gilead, Intercept"

Cynthia Levy, MD    "Advisory Committee or Review Panel: Intercept Pharma, Lumena
Consulting: Intercept, Lumena, Evidera
Grant/Research Support: Gilead, Novartis, NGM, Lumena, Intercept, Evidera, CymaBay, Merck, AbbVie, Bristol Myers Squibb, Tobira
Other: Associate Editor Liver Transplantation"

Michael F. Chang, MD    Nothing to Disclose

Josh Levitsky, MD, FAASLD    Consulting: Transplant Genomics Incorporated

William M. Lee, MD, FAASLD    "Consulting: Eli Lilly, Novartis, Sanofi
Grant/Research Support: Bristol Myers Squibb, Exalenz, Gilead, Merck, Ocera, Roche, TEM, Vertex"

Jaquelyn F. Fleckenstein, MD    Nothing to Disclose

Michael R. Lucey, MD, FAASLD    "Advisory Committees or Review Panels: Galectin
Grant/Research Support: Abbvie, Gilead, Salix, Vertex"

Arun J. Sanyal, MD, FAASLD    "Advisory Committees or Review Panels: Abbott, Bristol Myers, Exhalenz, Genfit, Gilead, Ikaria
Consulting: Echosens, Enanta, Exhalenz, Genentech, Immuron, Islet Sciences, JD Pharma, Merck, Nimbus, Salix, Takeda, Zafgen
Grant/Research Support: GalMed, Genentech, Gilead, Ikaria, Intercept, Novartis, Salix, Takeda, Tobira
Independent Contractor: Elsevier, UpToDate"

Michael D. Leise, MD    Nothing to Disclose

Elizabeth Pomfret, MD, PhD     Nothing to Disclose

Sarah J. Diamond, MD    Other: Nestle Clinical Nutrition Fellowship

Jorge A. Marrero, MD    "Advisory Committees or Review Panels: Bayer, Onyx
Grant/Research Support: Blueprint Medicine"

Philip Rosenthal, MD, FAASLD    "Advisory Committee or Review Panel:  Gilead, Retrophin
Consulting: Gilead, Abbvie, Retrophin
Grant/Research Support: Gilead, Abbvie, Bristol Myers Squibb, Roche/Genetech
Speakers' Bureau: Retrophin"

Jay A. Fishman, MD    "Advisory Committee or Review Panel: Revolution Medicines                                     
Employment: MGH
Grant/Research Support: NIH"

Mark W. Russo, MD, FAASLD    "Advisory Board: Abbvie, Gilead, Merck  
Grant/Research Support: Giliead, Merck
Speaking and Teaching: Abbvie, Gilead, Intercept, Merck, Salix"

Michael S. Kriss, MD    Nothing to Disclose

Pre and Post-transplant Hepatitis C
MOC & CME
Pre and Post-transplant Hepatitis B
MOC & CME
Pre and Post-transplant Non-alcoholic Fatty Liver Disease
MOC & CME
Autoimmune and Cholestatic Liver Disease
MOC & CME
Transplant Immunology
MOC & CME
Immunosuppression and Rejection
MOC & CME
Drug-induced Liver Injury
MOC & CME
Acute Liver Failure
MOC & CME
Liver Disease in the Pregnant Patient
MOC & CME
Alcoholic Liver Disease
MOC & CME
MELD/PELD, Candidate Selection, and Multi-organ Transplantation
MOC & CME
Surgical Complications of Liver Transplant
MOC & CME
Nutrition in the Cirrhotic Patient
MOC & CME
Hepatobiliary and Post-transplant Malignancy
MOC & CME
Pediatrics Breakout
MOC & CME
Infectious Complications Post-transplant
MOC & CME
Recurrent Disease Post-transplant
MOC & CME
Long-term Complications Post-transplant
MOC & CME
Potpourri
MOC & CME
Final Evaluation & Certificate/Completion Confirmation